APA (7th ed.) Citation

Calafiore, L., Amoroso, L., Della Casa Alberighi, O., Luksch, R., Zanazzo, G., Castellano, A., . . . Garaventa, A. (2013). Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma. Annals of Oncology, 24(5), 1406. https://doi.org/10.1093/annonc/mds648

Chicago Style (17th ed.) Citation

Calafiore, L., et al. "Two-stage Phase II Study of Imatinib Mesylate in Subjects with Refractory or Relapsing Neuroblastoma." Annals of Oncology 24, no. 5 (2013): 1406. https://doi.org/10.1093/annonc/mds648.

MLA (9th ed.) Citation

Calafiore, L., et al. "Two-stage Phase II Study of Imatinib Mesylate in Subjects with Refractory or Relapsing Neuroblastoma." Annals of Oncology, vol. 24, no. 5, 2013, p. 1406, https://doi.org/10.1093/annonc/mds648.